4.5 Article

Microglial activation in healthy aging

Journal

NEUROBIOLOGY OF AGING
Volume 33, Issue 6, Pages 1067-1072

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2010.09.016

Keywords

Aging; Microglial activation; PK11195; PET; Neurodegeneration

Funding

  1. European Commission [NCI-MCI (QLK6-CT-2000-00502)]
  2. Netherlands Brain Foundation [9F01.21]
  3. Netherlands Organisation for Scientific Research (NWO-VIDI) [016.066.09]

Ask authors/readers for more resources

Healthy brain aging is characterized by neuronal loss and decline of cognitive function. Neuronal loss is closely associated with microglial activation and postmortem studies have indeed suggested that activated microglia may be present in the aging brain. Microglial activation can be quantified in vivo using (R)-[C-11] PK11195 and positron emission tomography. The purpose of this study was to measure specific binding of (R)-[C-11] PK11195 in healthy subjects over a wide age range. Thirty-five healthy subjects (age range 19-79 years) were included. In all subjects 60-minute dynamic (R)-[C-11] PK11195 scans were acquired. Specific binding of (R)-[C-11] PK11195 was calculated using receptor parametric mapping in combination with supervised cluster analysis to extract the reference tissue input function. Increased binding of (R)-[C-11] PK11195 with aging was found in frontal lobe, anterior and posterior cingulate cortex, medial inferior temporal lobe, insula, hippocampus, entorhinal cortex, thalamus, parietal and occipital lobes, and cerebellum. This indicates that activated microglia appear in several cortical and subcortical areas during healthy aging, suggesting widespread neuronal loss. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available